A study of the relationship between socioeconomic factors and kinesiological fitness von Gilliland, Gary H

Volltext bestellen

The Changing Classroom By Carol Goodell, ed. (Book Review) von Gilliland, Gary H

Volltext

Integrated genomic analysis illustrates the central role of JAK-STAT pathway activation in myeloproliferative neoplasm pathogenesis von Rampal, Raajit, Al-Shahrour, Fatima, Abdel-Wahab, Omar, Patel, Jay P., Brunel, Jean-Philippe, Mermel, Craig H., Bass, Adam J., Pretz, Jennifer, Ahn, Jihae, Hricik, Todd, Kilpivaara, Outi, Wadleigh, Martha, Busque, Lambert, Gilliland, D. Gary, Golub, Todd R., Ebert, Benjamin L., Levine, Ross L.

Volltext

FoxOs Are Critical Mediators of Hematopoietic Stem Cell Resistance to Physiologic Oxidative Stress von Tothova, Zuzana, Kollipara, Ramya, Huntly, Brian J., Lee, Benjamin H., Castrillon, Diego H., Cullen, Dana E., McDowell, Elizabeth P., Lazo-Kallanian, Suzan, Williams, Ifor R., Sears, Christopher, Armstrong, Scott A., Passegué, Emmanuelle, DePinho, Ronald A., Gilliland, D. Gary

Volltext

Safety and Efficacy of TG101348, a Selective JAK2 Inhibitor, in Myelofibrosis von PARDANANI, Animesh, GOTLIB, Jason R, JAMIESON, Catriona, CORTES, Jorge E, TALPAZ, Moshe, STONE, Richard M, SILVERMAN, Michael H, GILLILAND, D. Gary, SHORR, Jolene, TEFFERI, Ayalew

Volltext

FoxOs Are Lineage-Restricted Redundant Tumor Suppressors and Regulate Endothelial Cell Homeostasis von Paik, Ji-Hye, Kollipara, Ramya, Chu, Gerald, Ji, Hongkai, Xiao, Yonghong, Ding, Zhihu, Miao, Lili, Tothova, Zuzana, Horner, James W., Carrasco, Daniel R., Jiang, Shan, Gilliland, D. Gary, Chin, Lynda, Wong, Wing H., Castrillon, Diego H., DePinho, Ronald A.

Volltext

Book Review Section 1 von Appleton, Nicholas, Bonneau, Loren R., Feinberg, Walter, Moore, Thomas D., Grande, Albert, Hedley, W. Eugene, Leith, D. Malcolm, Schindler, Charles R., Fels, Leonard, Wagschal, Harry, Jackson, Gregg, Williams, David C., Gilliland, Gary H., Greer, Colin, Gutek, Gerald L., Button, H. Warren, Goodenow, Ronald K.

Volltext

Book Review Section 1 von Appleton, Nicholas, Bonneau, Loren R., Feinberg, Walter, Moore, Thomas D., Grande, Albert, Hedley, W. Eugene, Leith, D. Malcolm, Schindler, Charles R., Fels, Leonard, Wagschal, Harry, Jackson, Gregg, Williams, David C., Gilliland, Gary H., Greer, Colin, Gutek, Gerald L., Button, H. Warren, Goodenow, Ronald K.

Volltext

MOZ-TIF2, but not BCR-ABL, confers properties of leukemic stem cells to committed murine hematopoietic progenitors von Huntly, Brian J.P., Shigematsu, Hirokazu, Deguchi, Kenji, Lee, Benjamin H., Mizuno, Shinichi, Duclos, Nicky, Rowan, Rebecca, Amaral, Sonia, Curley, David, Williams, Ifor R., Akashi, Koichi, Gilliland, D.Gary

Volltext

Highly Sensitive Method for Genomewide Detection of Allelic Composition in Nonpaired, Primary Tumor Specimens by Use of Affymetrix Single-Nucleotide–Polymorphism Genotyping Microar... von Yamamoto, Go, Nannya, Yasuhito, Kato, Motohiro, Sanada, Masashi, Levine, Ross L., Kawamata, Norihiko, Hangaishi, Akira, Kurokawa, Mineo, Chiba, Shigeru, Gilliland, D. Gary, Koeffler, H. Phillip, Ogawa, Seishi

Volltext

MPLW515L is a novel somatic activating mutation in myelofibrosis with myeloid metaplasia von Pikman, Yana, Lee, Benjamin H, Mercher, Thomas, McDowell, Elizabeth, Ebert, Benjamin L, Gozo, Maricel, Cuker, Adam, Wernig, Gerlinde, Moore, Sandra, Galinsky, Ilene, DeAngelo, Daniel J, Clark, Jennifer J, Lee, Stephanie J, Golub, Todd R, Wadleigh, Martha, Gilliland, D Gary, Levine, Ross L

Volltext

Expression of a Homodimeric Type I Cytokine Receptor Is Required for JAK2V617F-Mediated Transformation von Xiaohui Lu, Levine, Ross, Tong, Wei, Wernig, Gerlinde, Yana Pikman, Sara Zarnegar, Gilliland, D. Gary, Lodish, Harvey

Volltext

The Retinoblastoma Binding Protein RBP2 Is an H3K4 Demethylase von Klose, Robert J., Yan, Qin, Tothova, Zuzana, Yamane, Kenichi, Erdjument-Bromage, Hediye, Tempst, Paul, Gilliland, D. Gary, Zhang, Yi, Kaelin, William G.

Volltext

Efficacy of TG101348, a Selective JAK2 Inhibitor, in Treatment of a Murine Model of JAK2V617F-Induced Polycythemia Vera von Wernig, Gerlinde, Kharas, Michael G., Okabe, Rachel, Moore, Sandra A., Leeman, Dena S., Cullen, Dana E., Gozo, Maricel, McDowell, Elizabeth P., Levine, Ross L., Doukas, John, Mak, Chi Ching, Noronha, Glenn, Martin, Michael, Ko, Yon D., Lee, Benjamin H., Soll, Richard M., Tefferi, Ayalew, Hood, John D., Gilliland, D. Gary

Volltext

Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1 von Barbie, David A., Tamayo, Pablo, Boehm, Jesse S., Kim, So Young, Moody, Susan E., Dunn, Ian F., Schinzel, Anna C., Sandy, Peter, Meylan, Etienne, Scholl, Claudia, Fröhling, Stefan, Chan, Edmond M., Sos, Martin L., Michel, Kathrin, Mermel, Craig, Silver, Serena J., Weir, Barbara A., Reiling, Jan H., Sheng, Qing, Gupta, Piyush B., Wadlow, Raymond C., Le, Hanh, Hoersch, Sebastian, Wittner, Ben S., Ramaswamy, Sridhar, Livingston, David M., Sabatini, David M., Meyerson, Matthew, Thomas, Roman K., Lander, Eric S., Mesirov, Jill P., Root, David E., Gilliland, D. Gary, Jacks, Tyler, Hahn, William C.

Volltext

JAK2 Exon 12 Mutations in Polycythemia Vera and Idiopathic Erythrocytosis von Scott, Mike A, Scott, Linda M, Tong, Wei, Levine, Ross L, Beer, Philip A, Stratton, Michael R, Futreal, P. Andrew, Erber, Wendy N, McMullin, Mary Frances, Harrison, Claire N, Warren, Alan J, Gilliland, D. Gary, Lodish, Harvey F, Green, Anthony R

Volltext

The JAK2 V617F activating tyrosine kinase mutation is an infrequent event in both “atypical” myeloproliferative disorders and myelodysplastic syndromes von Steensma, David P., Dewald, Gordon W., Lasho, Terra L., Powell, Heather L., McClure, Rebecca F., Levine, Ross L., Gilliland, D. Gary, Tefferi, Ayalew

Volltext

Discovery of a novel ERK inhibitor with activity in models of acquired resistance to BRAF and MEK inhibitors von Morris, Erick J, Jha, Sharda, Restaino, Clifford R, Dayananth, Priya, Zhu, Hugh, Cooper, Alan, Carr, Donna, Deng, Yongi, Jin, Weihong, Black, Stuart, Long, Brian, Liu, Jenny, Dinunzio, Edward, Windsor, William, Zhang, Rumin, Zhao, Shuxia, Angagaw, Minilik H, Pinheiro, Elaine M, Desai, Jagdish, Xiao, Li, Shipps, Gerald, Hruza, Alan, Wang, James, Kelly, Joe, Paliwal, Sunil, Gao, Xiaolei, Babu, Boga Sobhana, Zhu, Liang, Daublain, Pierre, Zhang, Ling, Lutterbach, Bart A, Pelletier, Marc R, Philippar, Ulrike, Siliphaivanh, Phieng, Witter, David, Kirschmeier, Paul, Bishop, W Robert, Hicklin, Daniel, Gilliland, D Gary, Jayaraman, Lata, Zawel, Leigh, Fawell, Stephen, Samatar, Ahmed A

Volltext

mTOR Activation Induces Tumor Suppressors that Inhibit Leukemogenesis and Deplete Hematopoietic Stem Cells after Pten Deletion von Lee, Jae Y., Nakada, Daisuke, Yilmaz, Omer H., Tothova, Zuzana, Joseph, Nancy M., Lim, Megan S., Gilliland, D. Gary, Morrison, Sean J.

Volltext

FGFR3 Activates RSK2 to Mediate Hematopoietic Transformation through Tyrosine Phosphorylation of RSK2 and Activation of the MEK/ERK Pathway von Kang, Sumin, Dong, Shaozhong, Gu, Ting-Lei, Guo, Ailan, Cohen, Michael S., Lonial, Sagar, Khoury, Hanna Jean, Fabbro, Doriano, Gilliland, D. Gary, Bergsagel, P. Leif, Taunton, Jack, Polakiewicz, Roberto D., Chen, Jing

Volltext